Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL COMPOUNDS AND THEIR USES AS ACC INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2019/015583
Kind Code:
A1
Abstract:
The present invention provides compounds of Formula (I) which can be used as ACC inhibitors and potently as therapeutic agents against diseases mediated by ACC.

Inventors:
ZHANG JUNBO (CN)
LIAO HONG (CN)
WANG PEIPEI (CN)
WANG PENG (CN)
Application Number:
PCT/CN2018/095973
Publication Date:
January 24, 2019
Filing Date:
July 17, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NANJING RUIJIE PHARMATECH CO LTD (CN)
International Classes:
A61K31/519; C07D495/04; A61P3/00; C07D309/12; C07D493/10
Domestic Patent References:
WO2017151816A12017-09-08
WO2016112305A12016-07-14
WO2017091617A12017-06-01
WO2017091600A12017-06-01
WO2017151816A12017-09-08
WO2016112305A12016-07-14
Foreign References:
CN104105485A2014-10-15
CN105358155A2016-02-24
CN104105485A2014-10-15
CN105358155A2016-02-24
Other References:
HARRIMAN GERALDINE ET AL.: "Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats", PNAS, 14 March 2016 (2016-03-14), pages E1796 - E1805, XP055382605
DAVIS AMANDA L. ET AL.: "Trimming the fat in non-small cell lung cancer: a new small molecule inhibitor of acetyl-CoA carboxylase to target fatty acid synthesis", TRANSL CANCER RES, vol. 5, no. Suppl 7, 31 December 2016 (2016-12-31), pages S1449 - S1452, XP055565489
HARRIMAN GERALDINE ET AL., PNAS, vol. 14, 2016, pages E1796 - E1805
DAVIS AMANDA L. ET AL., TRANSL CANCER RES, vol. 5, 2016, pages S1449 - S1452
"Handbook of Chemistry and Physics", CAS, article "Periodic Table of the Elements"
ZUTHER ET AL.: "Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase", PNAS, vol. 96, no. 23, 1999, pages 13387 - 13392, XP055559954, DOI: 10.1073/pnas.96.23.13387
"March's Advanced Organic Chemistry", 2001, JOHN WILEY & SONS
S. M. BERGE ET AL., J. PHARMACEUTICAL SCIENCES, vol. 66, 1977, pages 1 - 19
HARWOOD ET AL.: "Isozyme-nonselective N-Substituted Bipiperidylcarboxamide Acetyl-CoA Carboxylase Inhibitors Reduce Tissue Malonyl-CoA Concentrations, Inhibit Fatty Acid Synthesis, and Increase Fatty Acid Oxidation in Cultured Cells and in Experimental Animals", J. BIOL. CHEM., vol. 278, 2003, pages 37099 - 37111, XP002580016, DOI: 10.1074/JBC.M304481200
TONGHARWOOD, J. CELLULAR BIOCHEM., vol. 99, 2006, pages 1476
ABU- ELHEIGA ET AL., PNAS (USA, vol. 102, 2005, pages 12011
CHENG ET AL., J. MED. CHEM., vol. 49, 2006, pages 1517
ABU-ELHEIGA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 100, 2003, pages 10207 - 10212
SAVAGE ET AL., J. CLIN. INVEST., vol. 116, 2006, pages 817
HARWOOD ET AL., J. BIOL. CHEM., vol. 278, 2003, pages 37099
FURLER ET AL., DIABETES, vol. 55, 2006, pages A333
TONG ET AL.: "Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery", CELL AND MOLECULAR LIFE SCIENCES, vol. 62, 2005, pages 1784 - 1803, XP019200809, DOI: 10.1007/s00018-005-5121-4
MAKOWSKI ET AL.: "Role of LKB1 in Lung Cancer Development", BRITISH JOURNAL OF CANCER, vol. 99, 2008, pages 683 - 688
WANG ET AL.: "Acetyl-CoA Carboxylase-alpha Inhibitor TOFA Induces Human Cancer Cell Apoptosis", BIOCHEM BIOPHYS RES COMMUN, vol. 385, no. 3, 2009, pages 302 - 306
CHAJES ET AL.: "Acetyl-CoA Carboxylase alpha Is Essential to Breast Cancer Cell Survival", CANCER RES, vol. 66, 2006, pages 5287 - 5294
BECKERS ET AL.: "Chemical Inhibition of Acetyl-CoA Carboxylase Induces Growth Arrest and Cytotoxicity Selectivity in Cancer Cells", CANCER RES, 2007, pages 8180 - 8187, XP055012148, DOI: 10.1158/0008-5472.CAN-07-0389
BRUSSELMANS ET AL.: "RNA Interference-Mediated Silencing of the Acetyl-CoA-Carboxylase-alpha Gene Induces Growth Inhibition and Apoptosis of Prostate Cancer Cells", CANCER RES, vol. 65, 2005, pages 6719 - 6725, XP009148978, DOI: 10.1158/0008-5472.CAN-05-0571
BRUNET ET AL.: "BRCA1 and Acetyl-CoA Carboxylase: The Metabolic Syndrom of Breast Cancer", MOLECULAR CARCINOGENESIS, vol. 47, 2008, pages 157 - 163
CAIRNS ET AL., REGULATION OF CANCER CELL METABOLISM, vol. 11, 2011, pages 85 - 95
CHIARADONNA ET AL.: "From Cancer Metabolism to New Biomarkers and Drug Targets", BIOTECHNOLOGY ADVANCES, vol. 30, 2012, pages 30 - 51, XP028439161, DOI: 10.1016/j.biotechadv.2011.07.006
PETTI ET AL.: "AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway", MELANOMA RESEARCH, vol. 22, 2012, pages 341 - 350
BRUNET ET AL.: "BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer", MOL. CARCINOG., vol. 47, no. 2, 2008, pages 157 - 163
OLSEN ET AL.: "Fatty acid synthesis is a therapeutic target in human liposarcoma", INTERNATIONAL J. OF ONCOLOGY, vol. 36, 2010, pages 1309 - 1314, XP002663603, DOI: 10.3892/IJO_00000616
SHEN ET AL.: "A Mechanism for the Potent Inhibition of Eukaryotic Acetyl-Coenzyme A Carboxylase by Soraphen A, a Macrocyclic Polyketide Natural Product", MOLECULAR CELL, vol. 16, 2004, pages 881 - 891, XP007903549, DOI: 10.1016/j.molcel.2004.11.034
TONG, L ET AL., J. CELL. BIOCHEM., vol. 99, 2006, pages 1476 - 1488
MUNGER ET AL., NAT. BIOTECHNOL., vol. 26, 2008, pages 1179 - 1186
HENDERSON ET AL., NEUROTHERAPEUTICS, vol. 5, 2008, pages 470 - 480
COSTANTINI ET AL., NEUROSCI, vol. 9, 2008, pages S16
BARANANO ET AL., CURR. TREAT. OPIN. NEUROL., vol. 10, 2008, pages 410 - 419
GORNICKI ET AL.: "Apicoplast fatty acid biosynthesis as a target for medical intervention in apicomplexan parasites", INTERNATIONAL JOURNAL OF PARASITOLOGY, vol. 33, 2003, pages 885 - 896
KOLWICZ ET AL.: "Cardiac-specific deletion of acetyl CoA carboxylase 2 (ACC2) prevents metabolic remodeling during pressure-overload hypertrophy", CIRC. RES., 2012
See also references of EP 3655409A4
Attorney, Agent or Firm:
BEIJING CELUE LAW FIRM (CN)
Download PDF: